Niemann-Pick disease type C is a clinically heterogeneous storage disorder with an unknown primary metabolic defect. We have undertaken somatic cell hybridisation experiments using skin fibroblast strains from 12 patients representing a wide clinical spectrum. Preliminary experiments using filipin staining of free cholesterol as a marker for complementation indicated the existence of one major group (group a) and one minor group (group 0) represented by one mutant strain. Subsequent experiments in which sphingomyelinase activity was measured as a marker for complementation using five mutant strains showing activity consistently < 40% control levels confirmed the existence of the second group.
The basic defect in the autosomal recessive storage disorder Niemann-Pick disease type C (NPC) is unknown, but appears to be related to a perturbation in the processing of exogenously derived cholesterol. ' 
SOURCE AND MAINTENANCE OF CULTURED CELLS
Skin fibroblast cultures were initiated from 12 patients (10 pedigrees including two sib pairs) with NPC, one each of NPA and I-cell disease patients, and several healthy controls. Strains were maintained up to the twentieth passage in 10% FBS-EMEM supplemented with glutamine (580 pg/ml), penicillin (100 U/ml), and streptomycin (100 gig/ml) in a humid 5% CO2 incubator.
NIEMANN-PICK DISEASE TYPE C PATIENTS
Individual NPC strains are identified by an Arabic numeral after the "NPC" abbreviation; sib pairs are distinguished by a small case letter after this numeral (for example, NPC-5a and NPC-5b). The NPC patients covered a broad phenotypic spectrum encompassing neurological, visceral, or neurovisceral pathology. figure E) ; however, strain NPC-2 exhibited positive complementation with any group a strain with which it was hybridised (example, figure F) 
Conclusion
Strain NPC-2 is from an Italian patient with an early onset of disease. Liver disease was apparent at birth, but neuronal involvement was not confirmed. Severe lung involvement 
